The FDA just changed the game for peptides. April 2026 The FDA is reviewing Category 2 peptides for potential removal from restricted status. Full approval for some peptides may be Peptide Research Overview Mechanisms, Applications & Insights January 2026 FDA New Drug Approvals Zycubo (copper histidinate) Some approvals mark progress. Others redefine what hope looks like. In January 2026, the U.S. FDA approved Zycubo (copper histidinate injection formerly GHK Cu (Copper Peptide) Therapy in South Florida Prescription Consultation & Medical Evaluation Telehealth Florida Surgery & Weight Loss Center GHK Cu [50mg] Elixser Peptides